Status:
COMPLETED
The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis
Lead Sponsor:
Aljazeera Hospital
Conditions:
Infertility
Autoimmune Thyroiditis
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
The aim of the work is to determine whether the use of immunomodulatory drugs could improve the reproductive of outcome of infertile patients who have autoimmune thyroiditis with positive autoimmune a...
Eligibility Criteria
Inclusion
- Infertility patients who have autoimmune thyroiditis With positive autoimmune thyroiditis and TSH level above 2 IU.
Exclusion
- All patients who have other autoimmune diseases especially antiphospholipid syndrome, hepatitis c viral disease.
- Patients who have any medical disorders ( eg. D.M. HTN .Epilepsy ….)
Key Trial Info
Start Date :
March 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2024
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT03289403
Start Date
March 7 2018
End Date
January 20 2024
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aljazeera (Al Gazeera) hospital
Giza, Egypt